Read more about Alkem Labs gains on launching affordable epilepsy drug on Business Standard. Alkem Laboratories rose 1.23% to Rs 3135.95 after the company announced the launch of Perampil (Perampanel) tablets 2 mg/4 mg/6 mg at affordable prices and improved patient access for epilepsy treatment in India.
Alkem Laboratories announced the launch of Perampil (Perampanel) tablets 2 mg/4 mg/6 mg on June 9 2021 to make the treatment accessible to patients and healthcare providers improving their quality of life.
Alkem has launched Perampil, at 2 mg - Rs. 49/strip of 7 tablets, 4 mg - Rs. 180/strip of 15 tablets and 6 mg - Rs. 300/strip of 15 tablets, to improve patient access.
This product reaffirms Alkem s commitment towards improving epilepsy care by bringing multiple treatment options of quality products to patients and health care professionals in India.
Alkem had also launched Brivasure (Brivaracetam) tablets in March 2021 for the adjunctive management of partial onset seizure with or without secondary generalization.
PHILADELPHIA – Various genetic alterations in circulating tumor cells (CTCs) were associated with clinical outcomes and resistance to hormone therapy in patients with metastatic castrate-resistant prostate cancer (mCRPC), according to results published in Molecular Cancer Research , a journal of the American Association for Cancer Research.
Read more about Student arrested for duping people on pretext of providing Remdesivir on Business Standard. A 18-year-old college student was arrested from Madhya Pradesh for allegedly cheating people on the pretext of providing them Remdesivir injections
Anti-viral drug Remdesivir would be made available directly to private hospitals to avoid overcrowding in places designated for its prescription based sale by state authorities to the kin of COVID-19 patients, the Tamil Nadu government said here on Sunday. Effective May 18, a facility would be made available to private hospitals to register their drug requirement in a portal and only their representatives should collect the medicine from sale depots. While information on the portal would soon be released, the hospitals must furnish information related to intended recipients, the oxygen dependent patients, the government said in an official release. The state-run Tamil Nadu Medical Services Corporation provided the drug to government hospitals.